Page last updated: 2024-09-02

fingolimod hydrochloride and krp-203

fingolimod hydrochloride has been researched along with krp-203 in 7 studies

Compound Research Comparison

Studies (fingolimod hydrochloride)	Trials (fingolimod hydrochloride)	Recent Studies (post-2010) (fingolimod hydrochloride)	Studies (krp-203)	Trials (krp-203)	Recent Studies (post-2010) (krp-203)
2,771	157	2,062	17	0	6

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (57.14)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Enosawa, S; Fukuchi, K; Hakamata, Y; Iwanami, S; Kaneko, T; Kishi, T; Kobayashi, E; Kudou, S; Kuriyama, K; Matsumoto, K; Morishita, Y; Murakami, T; Shimizu, H; Takahashi, M; Takeyoshi, I; Yasue, T	1
Kaneko, T; Kawana, H; Kobayashi, E; Murakami, T; Takahashi, M; Yasue, T	1
Huwiler, A; Pfeilschifter, J	1
Milstien, S; Paugh, SW; Spiegel, S; Takabe, K	1
Adachi, K; Hamada, M; Hikawa, H; Yokoyama, Y	1
Ebinuma, I; Isshiki, H; Iwatsubo, T; Osawa, S; Sasaki, T; Takasugi, N; Takeo, K; Tomita, T	1
Danese, S; Furfaro, F; Vetrano, S	1

Reviews

2 review(s) available for fingolimod hydrochloride and krp-203

Article	Year
New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets. Biochemical pharmacology, 2008, May-15, Volume: 75, Issue:10 Topics: Animals; Fingolimod Hydrochloride; Humans; Lysophospholipids; Oxadiazoles; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Pyrazoles; Pyridines; Receptors, Lysosphingolipid; Sphingosine; Sulfhydryl Compounds; Thiazolidines; Thiophenes	2008
"Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacological reviews, 2008, Volume: 60, Issue:2 Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Enzyme Activation; Fingolimod Hydrochloride; Humans; Hypersensitivity; Immunosuppressive Agents; Lysophospholipids; Multiple Sclerosis; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Sulfhydryl Compounds	2008

Article

Year

New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.

Biochemical pharmacology, 2008, May-15, Volume: 75, Issue:10

Topics: Animals; Fingolimod Hydrochloride; Humans; Lysophospholipids; Oxadiazoles; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Pyrazoles; Pyridines; Receptors, Lysosphingolipid; Sphingosine; Sulfhydryl Compounds; Thiazolidines; Thiophenes

2008

"Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets.

Pharmacological reviews, 2008, Volume: 60, Issue:2

Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Enzyme Activation; Fingolimod Hydrochloride; Humans; Hypersensitivity; Immunosuppressive Agents; Lysophospholipids; Multiple Sclerosis; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Sulfhydryl Compounds

2008

Other Studies

5 other study(ies) available for fingolimod hydrochloride and krp-203

Article	Year
KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Circulation, 2005, Jan-18, Volume: 111, Issue:2 Topics: Animals; Bradycardia; Chemotaxis, Leukocyte; Chronic Disease; Cyclosporine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Guinea Pigs; Heart Rate; Heart Transplantation; Immunosuppressive Agents; Male; Molecular Structure; Propylene Glycols; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Rats, Wistar; Skin Transplantation; Sphingosine; Sulfhydryl Compounds; Transplantation, Heterotopic; Transplantation, Homologous	2005
Sphingosine-1-phosphate receptor agonists suppress concanavalin A-induced hepatic injury in mice. Biochemical and biophysical research communications, 2006, Jun-23, Volume: 345, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Liver; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Sulfhydryl Compounds; Treatment Outcome	2006
Synthesis of a key intermediate for the preparation of FTY720 analogs. Chemical & pharmaceutical bulletin, 2012, Volume: 60, Issue:11 Topics: Alkynes; Benzene Derivatives; Catalysis; Fingolimod Hydrochloride; Immunosuppressive Agents; Palladium; Propylene Glycols; Sphingosine; Sulfhydryl Compounds	2012
FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons. PloS one, 2013, Volume: 8, Issue:5 Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Brain; Disease Models, Animal; Fingolimod Hydrochloride; Humans; Mice; Mice, Inbred BALB C; Neurons; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Signal Transduction; Sphingosine; Sulfhydryl Compounds	2013
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration. Journal of Crohn's & colitis, 2018, Aug-22, Volume: 12, Issue:suppl_2 Topics: Animals; Camphanes; Cell Movement; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Indans; Inflammatory Bowel Diseases; Leukocytes; Lysophospholipids; Molecular Targeted Therapy; Oxadiazoles; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Sulfhydryl Compounds; Sulfonamides	2018